101
Participants
Start Date
May 6, 2022
Primary Completion Date
October 31, 2024
Study Completion Date
October 31, 2025
OSTEOAMP
OSTEOAMP SELECT Fibers (derived from human bone allograft) rehydrated with bone marrow aspirate (BMA) and combined with local autogenous graft for use in lumbar interbody fusion of the lumbar spine.
Infuse
The Infuse Bone Graft/Medtronic Interbody Fusion Device consists of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2, known as dibotermin alfa) placed on an absorbable collagen sponge (ACS). rhBMP-2 is the active agent in the Infuse Bone Graft component. The ACS is a soft, white, pliable, absorbent implantable matrix for rhBMP-2.
RECRUITING
OrthoVirginia, Richmond
RECRUITING
West Virginia University, Morgantown
RECRUITING
Tennessee Orthopaedic Alliance, Nashville
RECRUITING
Orthopaedic Institute of Western Kentucky, Paducah
RECRUITING
Kansas Joint and Spine Specialists, Wichita
ACTIVE_NOT_RECRUITING
Spine Institute of Louisiana, Shreveport
RECRUITING
Austin Neurosurgeons, Austin
RECRUITING
Yale University, New Haven
RECRUITING
New England Baptist Hospital, Boston
Lead Sponsor
Bioventus LLC
INDUSTRY